Role of β₁-Integrin in Colorectal Cancer: Case-Control Study.
10.12771/emj.2017.40.2.77
- Author:
Bo Young OH
1
;
Kwang Ho KIM
;
Soon Sup CHUNG
;
Kyoung Sook HONG
;
Ryung Ah LEE
Author Information
1. Department of Surgery, Ewha Womans University School of Medicine, Seoul, Korea. ralee@ewha.ac.kr
- Publication Type:Original Article
- Keywords:
Integrins;
Circulating neoplastic cells;
Carcinoembryonic antigen;
Colorectal neoplasms
- MeSH:
Carcinoembryonic Antigen;
Case-Control Studies*;
Colorectal Neoplasms*;
Extracellular Matrix;
Humans;
Integrins;
Neoplastic Cells, Circulating;
RNA, Messenger
- From:The Ewha Medical Journal
2017;40(2):77-86
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
OBJECTIVES: In the metastatic process, interactions between circulating tumor cells (CTCs) and the extracellular matrix or surrounding cells are required. β1-integrin may mediate these interactions. The aim of this study was to investigate whether β1-integrin is associated with the detection of CTCs in colorectal cancer. METHODS: We enrolled 30 patients with colorectal cancer (experimental group) and 30 patients with benign diseases (control group). Blood samples were obtained from each group, carcinoembryonic antigen (CEA) mRNA for CTCs marker and β1-integrin mRNA levels were estimated by using reverse transcription-polymerase chain reaction, and the results were compared between the two groups. RESULTS: CEA mRNA was detected more frequently in colorectal cancer patients than in control patients (P=0.008). CEA mRNA was significantly reduced after surgery in the colorectal cancer patients (P=0.032). β1-integrin mRNA was detected more in colorectal cancer patients than in the patients with benign diseases (P<0.001). In colorectal cancer patients, expression of β1-integrin mRNA was detected more for advanced-stage cancer than for early-stage cancer (P=0.033) and was significantly decreased after surgery (P<0.001). In addition, expression of β1-integrin mRNA was significantly associated with that of CEA mRNA in colorectal cancer patients (P=0.001). CONCLUSION: In conclusion, β1-integrin is a potential prognostic factor following surgical resection in colorectal cancer patients. β1-integrin may be a candidate for use as a marker for early detection of micrometastatic tumor cells and for monitoring the therapeutic response in colorectal cancer patients.
